Epigenetic modulation of human breast cancer by metallofullerenol nanoparticles: in vivo treatment and in vitro analysis
Abstract
Multi-hydroxylated endohedral metallofullerenol [Gd@C82(OH)22]n
* Corresponding authors
a
Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanosciences and Technology of China, Beijing, China
E-mail:
liangxj@nanoctr.cn
b
Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China
E-mail:
zhaoyuliang@mail.ihep.ac.cn
c Center for Evidence-based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China
d Laboratory of Molecular Imaging, Department of Radiology, Howard University, Washington, DC, USA
Multi-hydroxylated endohedral metallofullerenol [Gd@C82(OH)22]n
J. Meng, J. Xing, Y. Wang, J. Lu, Y. Zhao, X. Gao, P. C. Wang, L. Jia and X. Liang, Nanoscale, 2011, 3, 4713 DOI: 10.1039/C1NR10898K
To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.
If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.
If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.
Read more about how to correctly acknowledge RSC content.
Fetching data from CrossRef.
This may take some time to load.
Loading related content